I can’t thank you enough for your [internet] presence, approach and info. It’s been enormously helpful for me in just ‘living with’ my wife’s cll. You and Harvey are truly extraordinary.
Bill M.
]]>Question: Can you make a few comments about those non-nucleated red blood cells in Harvey’s transplant?
Thanks,
Chip and Vera
]]>I check your notes of progress on Harvey daily. You and Harvey are in my thoughts and prayers. I am so thrilled with his progress.
I am now on IVIG again. Because of your gentle coaching and pushing and my acting up or out (which ever it is.) I get it!!
Blessings,
Rita
I have followed your diary entries with considerable self-interest. I am in “recovery” at the present time from CLL. With a rituximab/Solu-Medrol infusion I have rolled the WBC back into the normal range with healthy ANC and rapidly improving RBC and hemoglobin. However, I am not willing to wait for a resurgence of CLL again, and your diary has been most helpful in understanding the statistics behind cord blood cell transplantation. I like the odds that you quote from MDA, one of the two places I have visited. I am currently on loan to Seattle Cancer Care Alliance for the remaining infusions and follow-up with Dr. D.M. However, given Hutch/SCCA’s current view of transplantations, I will be turning to MDA and DR. K for advice. I watched my mother die because she was afraid of undergoing a heart operation that could have prolonged her life by 10 years or more 40 years ago. I have no intention of waiting until I am a “basket case” for an attempt at a stem transplant. Keep up the great work; you and Harvey are a great inspiration that has given me the courage to think proactively about stem transplant. Harvey, keep getting better; you deserve it because of your courage and internal strength.
Barry
]]>Getting GCSF (neutrophil growth factor) shots each day until the ANC is respectable seems to be a good idea to me. But I am just as happy that the protocol does not use erythropoietin drugs (such as Aranesp, Procrit) to goose red blood cell production. There has been a flood of bad news about using epo drugs in cancer patients and we have been reviewing this on http://www.clltopics.org for several years now. Using red blood cell transfusions as a stop gap measure and waiting for local production of RBC seems to be a safer way to go.
Chaya
]]>One thing that everyone should understand is that transfused RBCs and platelets never work as well as those manufactured endogenously…largely due to “storage” related degradation. A rough rule of thumb is a 10% or greater degradation in numbers (and, likely, greater degradation of O2 carrying capacity) right off the bat with ongoing degradation. That’s why transfusions are only (albeit important) stop-gap measures.
]]>Thanks for the update on your wife’s GVHD status. You are right, getting a stem cell transplant is not a quickie project, it takes long term commitment to getting healthy.
To answer Wayne’s question: as Bruce mentioned above, GVHD is considered to be less of an issue with cord blood, which is why it is acceptable to transplant patients in significantly less well matched HLA situations. For example Harvey’s cords were both 4 out of 6 HLA match, a far cry from the 10 out of 10 (or higher) matching mandated for adult donor transplants.
There are many theories as to why GVHD is less of a problem with cord blood. One of the more well accepted theories is that cord blood has higher percentage of T-regs (compared to effector T-cells) than adult stem cell collections. The higher proportion of T-regs is necessary in order for the fetus and mother to co-exist for the nine months of the pregnancy. The higher proportion of T-regs means early onset of acute GVHD is significantly modulated in cord blood transplants.
Tomorrow I will be publishing a full length article on the subject of GVHD, which will address this and many other issues related to the subject.
Bruce, best wishes to your wife. She is in good hands. Clive Zent is one of my favorite CLL experts, and I was very impressed by Dr. Hogan when I met him at Mayo several years back.
Chaya
]]>We learned yesterday from Drs. Zent and Hogan that they are seeing an average of 3 years of immune suppression for patients who have undergone a mini allo transplant. I informed Dr. Zent of “Harvey’s” progress. He said a lot of his patients were keeping him up to date.
Of course “Harvey” will likely not face many GvHD issues. This is one of the many nice things about the cord blood transplants and something that really wasn’t available to us only 2 short years ago! I personally think those who are diagnosed with CLL today will face a greatly improved set of choices when the time comes to make major treatment decisions. In the case of my wife she had approximately 7 years between diagnosis and transplant. CLL treatments seven years from today will likely be a much different animal. Better results, less toxicity, lower mortality rates, and more complete cures are certain to be the norm.
]]>